Bladder Urothelial Carcinoma — Trials

Bladder Urothelial Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

138 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 60
Recruiting: 23
Ph III recruiting: 3
Growth YoY: —
Industry share: 7%
Top sponsor: National Cancer Institute (NCI)
Termination share: 47.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (21)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02767921	sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer	terminated	Phase 1	2	University of Southern CaliforniaOTHER	1	Nov 24, 2021	clinicaltrials
NCT00072137	Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy	terminated	Phase 1	21	National Cancer Institute (NCI)NIH	1	Dec 23, 2014	clinicaltrials